Beate Häberle

2.4k total citations
42 papers, 1.1k citations indexed

About

Beate Häberle is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Beate Häberle has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Surgery and 12 papers in Oncology. Recurrent topics in Beate Häberle's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Vascular Malformations and Hemangiomas (8 papers) and Epigenetics and DNA Methylation (7 papers). Beate Häberle is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Vascular Malformations and Hemangiomas (8 papers) and Epigenetics and DNA Methylation (7 papers). Beate Häberle collaborates with scholars based in Germany, United States and Switzerland. Beate Häberle's co-authors include Dietrich von Schweinitz, Roland Kappler, Rebecka L. Meyers, Marcio H. Malogolowkin, Dolores López‐Terrada, Piotr Czauderna, Eiso Hiyama, Irene Schmid, Melanie Eichenmüller and Frank Berthold and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Beate Häberle

35 papers receiving 1.1k citations

Peers

Beate Häberle
Ekmel Tezel Türkiye
Claudio De Vito Switzerland
Mary Drinane United States
Yu Jin Kim South Korea
Beate Häberle
Citations per year, relative to Beate Häberle Beate Häberle (= 1×) peers Marta Colletti

Countries citing papers authored by Beate Häberle

Since Specialization
Citations

This map shows the geographic impact of Beate Häberle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Häberle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Häberle more than expected).

Fields of papers citing papers by Beate Häberle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Häberle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Häberle. The network helps show where Beate Häberle may publish in the future.

Co-authorship network of co-authors of Beate Häberle

This figure shows the co-authorship network connecting the top 25 collaborators of Beate Häberle. A scholar is included among the top collaborators of Beate Häberle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beate Häberle. Beate Häberle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Vanessa F., Richard Brill, Daniel Puhr‐Westerheide, et al.. (2025). Combining Reversible Electroporation and Bleomycin in Treatment of Arteriovenous Malformations. CardioVascular and Interventional Radiology. 48(11). 1632–1637.
2.
Puhr‐Westerheide, Daniel, Gloria Biechele, Beate Häberle, et al.. (2025). Safety and Clinical Outcome of Bleomycin-Electrosclerotherapy (BEST) Treating Lymphatic Malformations (LMs). CardioVascular and Interventional Radiology. 48(10). 1428–1437. 1 indexed citations
3.
Rangaswami, Arun, Angela D. Trobaugh‐Lotrario, Rudolf Maibach, et al.. (2024). Validation of the stratification for newly diagnosed hepatoblastoma: An analysis from the Children’s Hepatic tumors International Collaboration (CHIC) database. SHILAP Revista de lepidopterología. 5. 100206–100206.
4.
Schmidt, Vanessa F., Lutz Meyer, S Hengst, et al.. (2024). Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and children. European Radiology. 34(10). 6425–6434. 14 indexed citations
5.
Wildgruber, Moritz, Michael Köhler, Katja Masjosthusmann, Florian Hoffmann, & Beate Häberle. (2024). Complex Arterio-Portal-Venous Malformation of the Liver. JACC Case Reports. 29(12). 102337–102337. 1 indexed citations
6.
Schmidt, Vanessa F., Heiko Schulz, Beate Häberle, & Moritz Wildgruber. (2024). Fibro-Adipose Vascular Anomaly of the Lower Extremity. JACC Case Reports. 29(8). 102274–102274.
7.
Häberle, Beate, et al.. (2023). Use of Barbed Sutures for Congenital Diaphragmatic Hernia Repair. Children. 11(1). 35–35. 1 indexed citations
8.
Schwerd, Tobias, et al.. (2023). Children with Localized Crohn's Disease Benefit from Early Ileocecal Resection and Perioperative Anti-Tumor Necrosis Factor Therapy. European Journal of Pediatric Surgery. 34(3). 236–244. 5 indexed citations
9.
Schmidt, Vanessa F., Max Masthoff, Osman Öcal, et al.. (2021). Percutaneous Sclerotherapy of Venous Malformations of the Hand: A Multicenter Analysis. CardioVascular and Interventional Radiology. 44(10). 1543–1550. 8 indexed citations
10.
Hubertus, Jochen, Julia Ley‐Zaporozhan, Dietrich von Schweinitz, et al.. (2021). Total Psoas Muscle Area as a Marker for Sarcopenia Is Related to Outcome in Children With Neuroblastoma. Frontiers in Surgery. 8. 718184–718184. 32 indexed citations
11.
Regel, Ivonne, Melanie Eichenmüller, Ujjwal Mukund Mahajan, et al.. (2020). Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. Journal of Cancer Research and Clinical Oncology. 146(5). 1153–1167. 13 indexed citations
12.
Trippel, Franziska, Kristina Becker, Beate Häberle, et al.. (2015). Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma. Hepatology International. 10(2). 370–376. 9 indexed citations
13.
Ilmer, Matthias, Kristina Becker, Beate Häberle, et al.. (2015). Truncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage. Oncology Letters. 11(1). 870–878. 18 indexed citations
14.
Eichenmüller, Melanie, Franziska Trippel, Alexander Beck, et al.. (2014). The genomic landscape of hepatoblastoma and their progenies with HCC-like features. Journal of Hepatology. 61(6). 1312–1320. 151 indexed citations
15.
Simon, Thorsten, Beate Häberle, Barbara Hero, Dietrich von Schweinitz, & Frank Berthold. (2013). Role of Surgery in the Treatment of Patients With Stage 4 Neuroblastoma Age 18 Months or Older at Diagnosis. Journal of Clinical Oncology. 31(6). 752–758. 84 indexed citations
16.
Czauderna, Piotr, Dolores López‐Terrada, Eiso Hiyama, et al.. (2013). Hepatoblastoma state of the art. Current Opinion in Pediatrics. 26(1). 19–28. 206 indexed citations
17.
Assmann, Gerald, Roland Kappler, Evelyn Zeindl‐Eberhart, et al.. (2012). β-Catenin mutations in 2 nested stromal epithelial tumors of the liver—a neoplasia with defective mesenchymal-epithelial transition. Human Pathology. 43(11). 1815–1827. 24 indexed citations
18.
Eichenmüller, Melanie, Beate Hagl, Beate Häberle, et al.. (2008). Blocking the hedgehog pathway inhibits hepatoblastoma growth #. Hepatology. 49(2). 482–490. 81 indexed citations
19.
Serra, Alexandre, Beate Häberle, Inke R. König, et al.. (2008). Rare Occurrence of PHOX2b Mutations in Sporadic Neuroblastomas. Journal of Pediatric Hematology/Oncology. 30(10). 728–732. 18 indexed citations
20.
Häberle, Beate, et al.. (2002). Characteristics and Outcome of Thoracic Neuroblastoma. European Journal of Pediatric Surgery. 12(3). 145–150. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026